MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Executive functions"

  • 2017 International Congress

    Fluency boost from walking in Parkinson’s disease

    O. Barthelemy, R. Salazar, S. Neargarder, J. DeGutis, T. Ellis, A. Cronin-Golomb (Boston, MA, USA)

    Objective: Examine the impact of a motor task on verbal fluency in individuals with Parkinson’s disease (PD) Background: Dual-tasking, in which individuals engage simultaneously in…
  • 2017 International Congress

    Relationship between neuropsychological functioning and subjective measures of sleep quality in Parkinson Disease

    E. Montanaro, M. Zibetti, F. Dematteis, L. Lopiano (Torino, Italy)

    Objective: To analyze the relationship between subjectively reported sleep alterations and cognitive functions in a large series of advanced Parkinson Disease (PD) patients evaluated with…
  • 2017 International Congress

    Lack of accurate self-appraisal is equally likely in Mild Cognitive Impairment from Parkinson’s disease and Other Neurodegenerative Disorders

    J. Leverenz, A. Bonner-Jackson, D. Floden, H. Fernanadez, J. Pillai (Cleveland, OH, USA)

    Objective: To determine whether Parkinson's disease patients with mild cognitive impairment (PD-MCI) demonstrate more accurate self-appraisals of their cognitive deficits than non-PD individuals with amnestic…
  • 2017 International Congress

    Emotion regulation and neuropsychological status in psychogenic subtypes.

    B. Scott, A. Strutt, P. Lundberg-Love, A. Schmitt, J. Jankovic, D. Bowers (Gainesville, FL, USA)

    Objective: To determine whether cognitive dysfunction is associated with emotion regulation strategies and psychological distress in two psychogenic movement disorder (PMD) variants: non-epileptic seizures (PNES)…
  • 2017 International Congress

    Decisional capacity for Goals of Care in Parkinson’s Disease with Cognitive Concerns

    M. Abu Snineh, R. Camicioli, J. Miyasaki (Jerusalen, Israel)

    Objective: We sought to assess decisional capacity (DC) for Goals of Care (GOC) using the MacArthur Competence Assessment Tool (MacCAT) for Parkinson’s disease (PD) patients…
  • 2017 International Congress

    Effects of dopaminergic medication on executive function in Parkinson’s disease differs according to the clinical stage

    H. Murakami, M. Kezuka, R. Kon, M. Kawamura, K. Ono (Tokyo, Japan)

    Objective: We examined the effect of dopaminergic medication on executive function in 24 drug-naïve PD patients (de novo group) and in 21 PD patients on…
  • 2017 International Congress

    Development and validation of an alternative version of the Parkinson’s Disease-Cognitive Rating Scale

    R. Fernandez-Bobadilla, S. Martinez-Horta, J. Marin-Lahoz, A. Horta-Barba, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To develop and validate an alternative form of the PD-CRS (PD-CRS/AF) with the objective of providing a reliable and fully equivalent method of reassessment…
  • 2016 International Congress

    Catechol-o-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson’s disease

    Y. Zhang, Y. Zhang, K. Nie, S. Feng, L. Wang, J. Zhao, Z. Huang, L. Wang (Guangzhou, People's Republic of China)

    Objective: The Catechol-O-Methyltransferase (COMT) Val158Met polymorphism has been proposed to be associated with increased risk of PD and have a specific impact on dopamine-mediated prefrontal…
  • 2016 International Congress

    Dyskinesias-reduced-self-awareness and theory of mind in Parkinson’s disease: A novel frame of interpretation

    S. Palermo, M. Amanzio, M. Zibetti, L. Lopiano (Turin, Italy)

    Objective: To analyze the existence of a relationship between Dyskinesias-reduced-self-awareness (DRSA) and abilities related to cognitive and affective Theory of Mind (ToM), which may represent…
  • 2016 International Congress

    Dopamine modulates learning conflicting action-valence associations in Parkinson’s disease

    N.C. van Wouwe, D.O. Claassen, J.S. Neimat, S.A. Wylie (Nashville, TN, USA)

    Objective: To investigate the effect of dopaminergic medication in Parkinson's disease (PD) on learning to act and learning to withhold action based on rewarding versus…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley